BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12504668)

  • 1. Retroviral transfer of MRP1 and gamma-glutamyl cysteine synthetase modulates cell sensitivity to L-buthionine-S,R-sulphoximine (BSO): new rationale for the use of BSO in cancer therapy.
    Rappa G; Gamcsik MP; Mitina RL; Baum C; Fodstad O; Lorico A
    Eur J Cancer; 2003 Jan; 39(1):120-8. PubMed ID: 12504668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel bicistronic retroviral vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance protein 1 (MRP1) protects cells from MRP1-effluxed drugs and alkylating agents.
    Rappa G; Lorico A; Hildinger M; Fodstad Ø; Baum C
    Hum Gene Ther; 2001 Sep; 12(14):1785-96. PubMed ID: 11560771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein.
    Benderra Z; Trussardi A; Morjani H; Villa AM; Doglia SM; Manfait M
    Eur J Cancer; 2000 Feb; 36(3):428-34. PubMed ID: 10708946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.
    Vanhoefer U; Cao S; Minderman H; Toth K; Skenderis BS; Slovak ML; Rustum YM
    Clin Cancer Res; 1996 Dec; 2(12):1961-8. PubMed ID: 9816155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-glutamylcysteine synthetase and L-buthionine-(S,R)-sulfoximine: a new selection strategy for gene-transduced neural and hematopoietic stem/progenitor cells.
    Lorico A; Bratbak D; Meyer J; Kunke D; Krauss S; Plott WE; Solodushko V; Baum C; Fodstad O; Rappa G
    Hum Gene Ther; 2005 Jun; 16(6):711-24. PubMed ID: 15960602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-S,R-buthionine sulfoximine: historical development and clinical issues.
    Bailey HH
    Chem Biol Interact; 1998 Apr; 111-112():239-54. PubMed ID: 9679558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRP1 modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells.
    Gana CC; Hanssen KM; Yu DMT; Flemming CL; Wheatley MS; Conseil G; Cole SPC; Norris MD; Haber M; Fletcher JI
    Biochem Pharmacol; 2019 Oct; 168():237-248. PubMed ID: 31302132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation.
    Drew R; Miners JO
    Biochem Pharmacol; 1984 Oct; 33(19):2989-94. PubMed ID: 6148944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of 6-(methylsulfinyl)hexyl isothiocyanate for sensitization of tumor cells to antitumor agents in combination therapies.
    Yamaguchi H; Kidachi Y; Kamiie K; Noshita T; Umetsu H; Fuke Y; Ryoyama K
    Biochem Pharmacol; 2013 Aug; 86(4):458-68. PubMed ID: 23791871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
    Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylcysteine enhances multidrug resistance-associated protein 1 mediated doxorubicin resistance.
    Akan I; Akan S; Akca H; Savas B; Ozben T
    Eur J Clin Invest; 2004 Oct; 34(10):683-9. PubMed ID: 15473893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of L-buthionine-(S,R)-sulphoximine, an inhibitor of gamma-glutamylcysteine synthetase on peroxynitrite- and endotoxic shock-induced vascular failure.
    Cuzzocrea S; Zingarelli B; O'Connor M; Salzman AL; Szabó C
    Br J Pharmacol; 1998 Feb; 123(3):525-37. PubMed ID: 9504394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
    Kisara S; Furusawa S; Murata R; Ogata M; Hikichi N; Takayanagi Y; Sasaki K
    Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice.
    Reliene R; Schiestl RH
    Carcinogenesis; 2006 Feb; 27(2):240-4. PubMed ID: 16162646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanin content and downregulation of glutathione S-transferase contribute to the action of L-buthionine-S-sulfoximine on human melanoma.
    Fruehauf JP; Zonis S; al-Bassam M; Kyshtoobayeva A; Dasgupta C; Milovanovic T; Parker RJ; Buzaid AC
    Chem Biol Interact; 1998 Apr; 111-112():277-305. PubMed ID: 9679561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment.
    Yao K; Godwin AK; Ozols RF; Hamilton TC; O'Dwyer PJ
    Cancer Res; 1993 Aug; 53(16):3662-6. PubMed ID: 8101766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell lines.
    Sharp SY; Smith V; Hobbs S; Kelland LR
    Br J Cancer; 1998 Jul; 78(2):175-80. PubMed ID: 9683290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
    Mistry P; Loh SY; Kelland LR; Harrap KR
    Int J Cancer; 1993 Nov; 55(5):848-56. PubMed ID: 8244583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buthionine sulfoximine is a multitarget inhibitor of trypanothione synthesis in Trypanosoma cruzi.
    Vázquez C; Mejia-Tlachi M; González-Chávez Z; Silva A; Rodríguez-Zavala JS; Moreno-Sánchez R; Saavedra E
    FEBS Lett; 2017 Dec; 591(23):3881-3894. PubMed ID: 29127710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markedly decreased expression of glutathione S-transferase pi gene in human cancer cell lines resistant to buthionine sulfoximine, an inhibitor of cellular glutathione synthesis.
    Yokomizo A; Kohno K; Wada M; Ono M; Morrow CS; Cowan KH; Kuwano M
    J Biol Chem; 1995 Aug; 270(33):19451-7. PubMed ID: 7642628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.